Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/15/2001WO2001019853A3 Cell transfection
11/15/2001WO2001018244A3 Selection system
11/15/2001WO2001018191A3 Polynucleotides and polypeptides of the phosphoenolpyruvate carboxylase kinase (pepc kinase) family and their variants
11/15/2001WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001WO2001016150A3 Nucleoside analogues
11/15/2001WO2001011065A3 Hepatitis a virus clones adapted for growth in agmk cells
11/15/2001WO2001009304A3 Polynucleotides encoding aminolevulinic acid biosynthetic enzymes
11/15/2001WO2001007088A3 Methods for treating therapy-resistant tumors
11/15/2001WO2001004344A3 Induction of a th1-like response in vitro
11/15/2001WO2001003717A3 Methods of inducing cell death
11/15/2001WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001WO2001000880A3 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/15/2001WO2000078950A3 Differentially expressed genes in the adipocytes of obese mice
11/15/2001WO2000075352A3 Hcv/bvdv chimeric genomes and uses thereof
11/15/2001WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001WO2000058365A9 Specific binding proteins for treating canine allergy
11/15/2001WO2000055323A9 Differential expression of organellar gene products
11/15/2001WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001WO2000052141A9 Cells resistant to toxic genes and uses thereof
11/15/2001WO2000047729A9 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/15/2001WO2000047715A3 Dwf4 polynucleotides, polypeptides and uses thereof
11/15/2001WO2000046369A3 Polynucleotides related to pancreatic disease
11/15/2001WO2000044223A9 Use of a formulation for controlling expression of a target gene
11/15/2001WO2000031245A8 Creatine amidinohydrolase and process for producing the same
11/15/2001WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001WO2000020619A8 Secreted renilla luciferase
11/15/2001WO2000015819A9 Packaging cell lines for hiv-derived retroviral vector particles
11/15/2001US20010042257 Transgenic cell
11/15/2001US20010042256 Genetic engineering
11/15/2001US20010042255 Nucleic acids
11/15/2001US20010041965 Polymorphism detection utilizing clustering analysis
11/15/2001US20010041787 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
11/15/2001US20010041681 Therapeutically useful synthetic oligonucleotides
11/15/2001US20010041679 Multiple site delivery of adenoviral vector for the induction of angiogenesis
11/15/2001US20010041668 Selecting compound that is functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue, causing the compound to access the cells to stimulate cells to undergo hematopoiesis and vascular growth
11/15/2001US20010041362 Genetic engineering
11/15/2001US20010041361 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/15/2001US20010041360 Human DNase I variants
11/15/2001US20010041357 Polymerase chain reaction
11/15/2001US20010041356 Novel subunits of NADH dehydrogenase
11/15/2001US20010041355 Regulation of human nerve growth factor-related G protein-coupled receptor
11/15/2001US20010041354 Genetic engineering
11/15/2001US20010041353 Isolated nucleic acids
11/15/2001US20010041348 Animal sperm cell membrane
11/15/2001US20010041340 Genetic engineering
11/15/2001US20010041339 Bundling fibers; gluing to backing
11/15/2001US20010041337 Polypeptides
11/15/2001US20010041335 Methods and compositions for amplifying detectable signals in specific binding assays
11/15/2001US20010041334 Genetic engineering
11/15/2001US20010041332 Isolation nucleic acids by binding to solid phase
11/15/2001US20010041331 Methods of utilizing the TT virus
11/15/2001US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001US20010041175 Applying a recombinant insect virus containing a vector which is highly virulent to the locus, foliage or stem of a transgenic crop; nonpolluting
11/15/2001US20010041173 Helper-dependent cloning vectors where most viral genes have been removed and have increased safety and capacity for larger insertions
11/15/2001DE10023400A1 New acyl-carrier protein gene, acp, from coryneform bacteria, useful for increasing fermentative production of amino acids, especially lysine
11/15/2001DE10022362A1 Verfahren zum Auffinden von Modulatoren von Enzymen des Carotenoid-Biosyntheseweges A method for finding modulators of enzymes of the carotenoid biosynthesis pathway
11/15/2001DE10021834A1 New mRNA indicative of T cell activation and functional status, useful for diagnosis and therapy e.g. of autoimmunity or transplant rejection
11/15/2001DE10021688A1 New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
11/15/2001DE10019119A1 New leukotriene Bx receptor gene, LTBx, useful for diagnosis and treatment of LTBx-related diseases
11/15/2001CA2768046A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001CA2445398A1 Resistance to acetohydroxyacid synthase-inhibiting herbicides
11/15/2001CA2409714A1 Modification of bacteria
11/15/2001CA2409679A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001CA2409505A1 Plant promoter
11/15/2001CA2408921A1 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001CA2408911A1 Genetic transformation in plants using site-specific recombination and wide hybridization
11/15/2001CA2408840A1 Myc targets
11/15/2001CA2408828A1 Novel serine-threonine kinase-4
11/15/2001CA2408812A1 Methods of identifying the activity of gene products
11/15/2001CA2408738A1 Virulence genes, proteins, and their use
11/15/2001CA2408732A1 Modified es cells and es cell-specific gene
11/15/2001CA2408665A1 Novel regulator of g protein signalling
11/15/2001CA2408664A1 F-box containing protein
11/15/2001CA2408652A1 A method for designing and screening random libraries of compounds
11/15/2001CA2408632A1 Ph domain-interacting protein
11/15/2001CA2408594A1 Human monoclonal antibodies to dendritic cells
11/15/2001CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
11/15/2001CA2408545A1 The use of proteinaceous molecules in methods for molecular computing
11/15/2001CA2408468A1 Serine-threonine kinase-3
11/15/2001CA2408357A1 Production of conjugated linoleic and linolenic acids in plants
11/15/2001CA2408349A1 Method of regulating angiogenesis unsing ryk protein
11/15/2001CA2408344A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection
11/15/2001CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001CA2408268A1 Identifying clusters of transcription factor binding sites
11/15/2001CA2408253A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/15/2001CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001CA2408196A1 Sphingosine kinase and uses thereof
11/15/2001CA2408166A1 Presenilin enhancers
11/15/2001CA2408124A1 Transgenically produced decorin
11/15/2001CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001CA2408038A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001CA2408010A1 Identification of neural defects associated with the nucleosomal assembly protein 1l2 gene
11/15/2001CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001CA2407955A1 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001CA2407937A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
1 ... 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 ... 4023